These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Nuki G; Bresnihan B; Bear MB; McCabe D; Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
6. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717 [TBL] [Abstract][Full Text] [Related]
8. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396 [TBL] [Abstract][Full Text] [Related]
9. Multicenter double-blind trial of interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Lemmel EM; Gaus W; Hofschneider PH Arthritis Rheum; 1991 Dec; 34(12):1621-2. PubMed ID: 1747148 [No Abstract] [Full Text] [Related]
10. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A; Ma C; Ahdieh H; Galer BS Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450 [TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis. Weisman MH Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843 [TBL] [Abstract][Full Text] [Related]
12. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534 [TBL] [Abstract][Full Text] [Related]
13. Diclofenac (Voltarol) in rheumatoid arthritis: a report of a double-blind trial. Doreen MS; Boardman PL; Fowler PD; Poole PH Rheumatol Rehabil; 1979; Suppl 2():78-80. PubMed ID: 394280 [TBL] [Abstract][Full Text] [Related]
14. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711 [TBL] [Abstract][Full Text] [Related]
15. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461 [TBL] [Abstract][Full Text] [Related]
16. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB; Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469 [TBL] [Abstract][Full Text] [Related]